Phase I/II Open-Label Trial of UGX202 for Advanced Retinitis Pigmentosa
Phase I/II Open-Label Trial of UGX202 for Advanced Retinitis Pigmentosa
Not yet recruiting · NCT07847723 · Registry updated 2026-10-02Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Phase I/II Open-Label Trial of UGX202 for Advanced Retinitis Pigmentosa | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Eye Diseases, Hereditary, eye disorder, hereditary disease, inherited retinal dystrophy, retinal degeneration, retinal disorder, retinitis pigmentosa | Not yet recruiting | Phase 1 | 2026-10-02 | NCT07847723 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Suzhou UgeneX Therapeutics Co., Ltd. | 2 |
0 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| No products are listed yet. | |||